Prascend Tablets contain pergolide for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each Prascend Tablet contains 1 mg pergolide mesylate. Administer orally once daily at the rate directed.
Available in 60 or 160 tablets
